Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
CLEARLINE CAPITAL LP | 08-15-2022 | 06-30-2022 | 141 | 773,919,000 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
NAUTILUS BIOTECHNOLOGY INC | COM | 201 | $706,000 | 262,360 | 0.09 | 0.13 | 33,835 | 14.81 | 06-30-2022 |
LYRA THERAPEUTICS INC | COM | 202 | $673,000 | 119,128 | 0.09 | 0.03 | 54,266 | 83.66 | 06-30-2022 |
VINCERX PHARMA INC | COM NEW | 203 | $597,000 | 452,184 | 0.08 | 0.15 | 321,328 | 245.56 | 06-30-2022 |
ACHIEVE LIFE SCIENCES INC | COM | 204 | $586,000 | 120,094 | 0.08 | 0.10 | -1,918 | -1.57 | 06-30-2022 |